XML 69 R37.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Stock-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Schedule Of Share Based Compensation Shares Authorized Under Stock Plans Issued And Avaliability |
(in thousands) |
Common stock authorized | 19,000 |
Stock-based awards, including restricted stock and stock options granted, net of expired or cancelled awards | (8,589) |
Common stock available for grant of stock-based awards as of December 31, 2024 | 10,411 |
In addition, vested and unvested options to purchase 31 shares of common stock and 133 shares of unvested restricted stock awarded under the 2006 Plan were outstanding as of December 31, 2024.
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | The following weighted average assumptions were used for stock options granted during 2024, 2023, and 2022:
| Years Ended December 31,
| 2024 |  | 2023 |  | 2022
Volatility | 34.1% to 47.4% |  | 37.3% to 48.1% |  | 42.5% to 51.1%
Risk free interest rate | 4.0% to 4.6% |  | 3.7% to 4.7% |  | 1.2% to 3.0%
Expected life in years | 3.0 to 4.0 |  | 3.0 to 5.0 |  | 3.0 to 5.0
Dividend yield | 2.0% |  | 2.5% |  | 2.1%
Weighted average fair value | $13.22 |  | $10.12 |  | $13.42
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs | For the years ended December 31, 2024, 2023, and 2022, the total equity-based compensation costs were as follows:
| Years Ended December 31,
(in thousands) | 2024 |  | 2023 |  | 2022
Restricted stock awards | $ | 22,281 |  |  | $ | 21,301 |  |  | $ | 20,755 |
Stock options | 2,459 |  |  | 2,597 |  |  | 3,391 |
Performance-based awards | 1,799 |  |  | 250 |  |  | 250 |
Total | $ | 26,539 |  |  | $ | 24,148 |  |  | $ | 24,396 |
Schedule of cash proceeds and intrinsic values for stock options exercised table text block | Stock Options Activity relating to stock options granted under the Company’s plans during the year ended December 31, 2023 and 2024 was as follows:
(in thousands except per share data) | Number of Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term |  | Aggregate Intrinsic Value
Outstanding at January 1, 2023 | 2,766 |  |  | $ | 29.82 |  |  |  |  |
Granted | 237 |  |  | 30.74 |  |  |  |  |
Exercised | (1,654) |  |  | 25.14 |  |  |  |  |
Expired | (229) |  |  | 36.01 |  |  |  |  |
Forfeited | (2) |  |  | 46.28 |  |  |  |  |
Outstanding at December 31, 2023 | 1,118 |  |  | $ | 35.62 |  |  | 3.2 years |  | $ | 7,684 |
Vested and Exercisable at December 31, 2023 | 935 |  |  | $ | 35.91 |  |  | 3.0 years |  | $ | 6,167 |
Outstanding at January 1, 2024 | 1,118 |  |  | 35.62 |  |  |  |  |
Granted | 233 |  |  | 41.32 |  |  |  |  |
Exercised | (73) |  |  | 32.76 |  |  |  |  |
Expired | (2) |  |  | 46.47 |  |  |  |  |
Forfeited | (8) |  |  | 34.54 |  |  |  |  |
Outstanding at December 31, 2024 | 1,268 |  |  | $ | 36.82 |  |  | 2.7 years |  | $ | 7,611 |
Vested and Exercisable at December 31, 2024 | 1,116 |  |  | $ | 36.24 |  |  | 2.4 years |  | $ | 7,371 |
As of December 31, 2024, $1,326 of total unrecognized compensation cost related to non-vested stock option awards is expected to be recognized on a straight-line basis over a weighted-average period of 0.9 years. Additional information pertaining to the Company's stock option plan was as follows:
| Years Ended December 31,
(in thousands except per share data) | 2024 |  | 2023 |  | 2022
Weighted-average grant date fair value of awards granted | $ | 41.32 |  |  | $ | 30.74 |  |  | $ | 36.95 |
Cash received from the exercise of stock options | $ | 1,613 |  |  | $ | 1,205 |  |  | $ | 602 |
Intrinsic value of stock options exercised | $ | 791 |  |  | $ | 16,335 |  |  | $ | 314 |
Tax benefits realized on exercise of stock options | $ | 39 |  |  | $ | 1,285 |  |  | $ | 41 |

X
- Definition Tabular disclosure for the exercised stock options during the reporting period aggregate intrinsic value (except for nonpublic entities) and value of proceeds. + References No definition available. + Details
Name: | shoo_ScheduleOfCashProceedsAndIntrinsicValuesForStockOptionsExercisedTableTextBlockTableTextBlock
Namespace Prefix: | shoo_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number of shares under the Company Stock Incentive Plan of common stock authorized for use, stock-based awards issued (net of expired or canceled), and the amount of common stock available for grant of stock-based awards. + References No definition available. + Details
Name: | shoo_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockPlansIssuedAndAvaliabilityTableTextBlockTableTextBlock
Namespace Prefix: | shoo_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration